日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association Between Sarcopenic Obesity-Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study

肌少症肥胖相关评分与脂肪肝患者肝纤维化之间的关联：一项横断面研究

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics16020324
Ichikawa, Tatsuki; Miuma, Satoshi; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Yajima, Hiroyuki; Miyazaki, Osamu; Ikeda, Tomonari; Okamura, Takuma; Komatsu, Naohiro; Kakizoe, Mayuko; Tanaka, Ryusei; Miyaaki, Hisamitsu
肥胖
脂肪肝
代谢
发表日期：2026
文献求助 收藏

Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease

细胞角蛋白18片段与脂肪肝患者的脂肪变性相关纤维化评估评分和血脂水平相关。

期刊:World Journal of Hepatology
影响因子:2.5
doi:10.4254/wjh.v17.i11.110698
Ichikawa, Tatsuki; Miuma, Satoshi; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Yajima, Hiruyuki; Miyazaki, Osamu; Ikeda, Tomonari; Okamura, Takauma; Komatsu, Naohiro; Yoshino, Miruki; Miyaaki, Hisamitsu
细胞生物学
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Impact of weight loss and lifestyle modifications on liver fibrosis in MASLD and MetALD: A cohort study

体重减轻和生活方式改变对代谢相关肝病和代谢性肝病患者肝纤维化的影响：一项队列研究

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2025.2036
Ichikawa, Tatsuki; Miuma, Satoshi; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Yajima, Hiroyuki; Miyazaki, Osamu; Ikeda, Tomonari; Okamura, Takuma; Komatsu, Naohiro; Yoshino, Miruki; Miyaaki, Hisamitsu
代谢
发表日期：2025
文献求助 收藏

Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis.

肠道脂肪酸结合蛋白水平升高可作为肝硬化患者门静脉高压和胃食管静脉曲张的标志物

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-76040-6
Miuma Satoshi, Miyaaki Hisamitsu, Taura Naota, Kanda Yasuko, Matsuo Satoshi, Tajima Kazuaki, Takahashi Kosuke, Nakao Yasuhiko, Fukushima Masanori, Haraguchi Masafumi, Sasaki Ryu, Ozawa Eisuke, Ichikawa Tatsuki, Nakao Kazuhiko
其它
肠道菌群
发表日期：2024
文献求助 收藏

PIVKA‑II is associated with liver function, bone metabolism, and muscle function in patients with liver disease

PIVKA-II 与肝病患者的肝功能、骨代谢和肌肉功能相关。

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2023.1690
Honda, Takuya; Ichikawa, Tatsuki; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Honda, Tetsurou; Yajima, Hiroyuki; Miyazaki, Osamu; Kuribayashi, Yasutaka; Ikeda, Tomonari; Okamura, Takuma; Nagata, Kazuyoshi; Nakao, Kazuhiko
代谢
发表日期：2024
文献求助 收藏

Serum immunoglobulin A levels: Diagnostic utility in alcoholic liver disease and association with liver fibrosis in steatotic liver disease

血清免疫球蛋白A水平：在酒精性肝病诊断中的应用价值及其与脂肪肝疾病中肝纤维化的相关性

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2024.1830
Ichikawa, Tatsuki; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Yajima, Hiroyuki; Miyazaki, Osamu; Ikeda, Tomonari; Okamura, Takuma; Nagata, Kazuyoshi; Sawa, Kenichi; Niiya, Kazutaka; Nakao, Kazuhiko
代谢
免疫/内分泌
脂肪肝
发表日期：2024
文献求助 收藏

Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide

接受替诺福韦艾拉酚胺治疗的慢性乙型肝炎患者中，抗酒石酸酸性磷酸酶同工酶5b水平（一种骨代谢标志物）的变化

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2021.1489
Okamura, Takuma; Ichikawa, Tatsuki; Miyaaki, Hisamitsu; Miuma, Satoshi; Motoyoshi, Yasuhide; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Honda, Tetsurou; Yajima, Hiroyuki; Miyazaki, Osamu; Kuribayashi, Yasutaka; Ikeda, Tomonari; Taura, Naota; Nakao, Kazuhiko
代谢
肝炎
发表日期：2022
文献求助 收藏

Direct‑acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C

直接抗病毒治疗可降低慢性丙型肝炎男性患者血清中未羧化骨钙素的水平。

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2022.1567
Ichikawa, Tatsuki; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Honda, Tetsurou; Yajima, Hiroyuki; Miyazaki, Osamu; Kuribayashi, Yasutaka; Ikeda, Tomonari; Okamura, Takuma; Nakao, Kazuhiko
微生物学
肝炎
发表日期：2022
文献求助 收藏

Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease

比较计算的体肌量和SARC-F作为慢性肝病患者肌少症筛查方法

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2021.1410
Ichikawa, Tatsuki; Miyaaki, Hisamitsu; Miuma, Satoshi; Motoyoshi, Yasuhide; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Nakano, Yusuke; Honda, Tetsurou; Yajima, Hiroyuki; Uehara, Ryouhei; Miyazaki, Osamu; Kuribayashi, Yasutaka; Kira, Keiji; Taura, Naota; Nakao, Kazuhiko
ARC
发表日期：2021
文献求助 收藏

Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease

血清肌酐和胱抑素C计算的指标可作为肝病中肝损伤、肌肉力量和肌少症的预测因子

期刊:Biomedical Reports
影响因子:1.9
doi:10.3892/br.2020.1273
Ichikawa, Tatsuki; Miyaaki, Hisamitsu; Miuma, Satoshi; Motoyoshi, Yasuhide; Yamashima, Mio; Yamamichi, Shinobu; Koike, Makiko; Takahashi, Youichi; Honda, Tetsurou; Yajima, Hiroyuki; Uehara, Ryouhei; Hino, Naoyuki; Hirata, Ryousuke; Taura, Naota; Nakao, Kazuhiko
毒理研究
肝损伤
发表日期：2020
文献求助 收藏